AVGO delivered its Q2 earnings on June 3 and the market's verdict was swift — the stock closed at $481.57, up 4.7% on the day and 14% on the week, breaking cleanly above the analyst target cluster that had been framing the pre-earnings setup.
The earnings reaction is the story this week, and it marks a genuine change from where the last three notes left off. Those notes flagged a stock priced for perfection, with analysts nearly unanimous and the borrow market entirely relaxed — the risk being that strong results were already in the price. The Q2 print cleared that bar. At $481.57, Broadcom has now moved above the Morgan Stanley $485 target and is closing in on the Susquehanna and UBS targets at $490. Wells Fargo's $545 remains the outlier at the high end, but the rest of the Street is quickly becoming in-the-money on targets set only weeks ago. The next question is whether analysts revise higher following the print, or whether the consensus begins to look stretched from the other direction.
The borrow market and short positioning confirm this is not a squeeze story — it's genuine re-rating on fundamentals. Short interest is 1.1% of free float, down another 2.3% on the week and 4.1% over the past month. Shorts have been quietly covering into strength. Borrow availability is entirely unconstrained — the lending pool remains effectively open — and cost to borrow has eased to 0.21%, near the low end of its recent range. There is no short camp building against this move, no technical squeeze pressure, and no sign of forced buying. The rally is clean.
Options positioning has actually relaxed slightly into and through the print. The put/call ratio at 1.11 is marginally below its 20-day mean of 1.14 — a fraction of a standard deviation below, placing it toward the lower half of its 52-week band between 0.89 and 1.23. Heading into earnings, the previous notes noted an absence of defensive hedging. That remains true after the result. Options traders are not rushing to add protection at these levels, which is consistent with a market that accepted the print as validating the bull thesis rather than worrying about further downside.
The Street reaction will crystallise in the coming days. Heading in, 35 analysts had buy-equivalent ratings with no visible bears. Morgan Stanley (Overweight, $485) and Wells Fargo (Overweight, $545) bookend the range of conviction. Bulls point to AI networking silicon demand, the Google and Anthropic infrastructure partnerships, and the steady cash generation from non-AI semiconductor and infrastructure software revenue. Bears, to the extent they exist, flag the cyclicality of semiconductors broadly, geopolitical exposure on export controls, and a valuation that was already demanding before this week's additional leg. The P/E has moved to roughly 33.5x and the price-to-book to 17x — both up materially on the week. The EV/EBITDA at 26.4x has also expanded. These are not cheap multiples for a company where the growth argument now needs to compound further to justify the price.
Among peers, the week's moves were broad but AVGO was not the standout gainer. MRVL surged 39.6% on the week — likely on its own results-related catalyst — and ALAB added 11.6%. CRDO gained a more modest 3.3%. Broadcom's 14% weekly gain was strong in absolute terms but sits in the middle of the cohort, suggesting the sector as a whole is catching a bid rather than Broadcom alone driving the narrative.
The ORTEX short score of 29.5 remains low and has barely moved over the past two weeks, consistent with a stock that neither the data nor the positioning community is treating as a short candidate. Factor scores show strength in analyst consensus differentiation (91st percentile) and dividend quality (98th percentile), though the EV/EBIT ranking at 36 reflects the stretched valuation. What to watch now is whether the post-earnings analyst revision cycle pushes consensus targets materially above $500, and whether the price can sustain a premium to freshly revised targets — a threshold test it failed to clear in the weeks before this result.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
